A comprehensive evaluation of these supplements within evidence-based frameworks is essential to guide their safe and effective integration into clinical practice
During this initial week, you might find that you cannot finish a meal that you previously would have finished entirely, or you may notice that food noisethe constant, intrusive thoughts about what to eat nextbegins to quiet down
tirzepatide side effects Because both medications act on GLP-1 receptors, they share a similar side effect profile
GLP-1 receptor agonists are approved primarily for type 2 diabetes and, in some formulations, for weight management
In these very high-risk patients, GLP-1 receptor agonists reduce overall mortality, with an NNT of 42 (95% CI, 29 to 84) over five years
doi:10.1016/j.tibs.2004.01.007